Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

NCT02241590 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis Due to Hepatitis B Virus

Interventions

DRUG: Entecavir + Placebo
DRUG: Entecavir + Fuzheng Huayu Tablet

Sponsor

ShuGuang Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]